Security Agreements in the Biotechnology Industry
277 Contracts & Agreements
- ABEONA THERAPEUTICS INC. (1 contract)
- Achaogen, Inc. (2)
- Acorda Therapeutics (1)
- Adaptimmune Therapeutics PLC (2)
- Adhera Therapeutics, Inc. (15)
- ADiTx Therapeutics, Inc. (10)
- ADMA BIOLOGICS, INC. (3)
- Advaxis, Inc. (5)
- AGENUS INC (2)
- AgeX Therapeutics, Inc. (2)
- Akebia Therapeutics, Inc. (1)
- Aldeyra Therapeutics, Inc. (2)
- Alexion Pharmaceuticals (1)
- Allarity Therapeutics, Inc. (2)
- Alliqua BioMedical, Inc. (1)
- ALNYLAM PHARMACEUTICALS, INC. (1)
- APPLIED GENETIC TECHNOLOGIES CORP (1)
- Aptevo Therapeutics Inc. (1)
- AquaBounty Technologies, Inc. (3)
- AQUINOX PHARMACEUTICALS, INC (2)
- Arcturus Therapeutics Holdings Inc. (1)
- ARENA PHARMACEUTICALS INC (1)
- Aridis Pharmaceuticals, Inc. (2)
- ARROWHEAD PHARMACEUTICALS, INC. (1)
- Athenex, Inc. (2)
- AVEO PHARMACEUTICALS INC (3)
- Avid Bioservices, Inc. (4)
- BioCardia, Inc. (2)
- BIOCEPT INC (1)
- BioRestorative Therapies, Inc. (2)
- Biostage, Inc. (3)
- BIOTIME INC (4)
- BIOXYTRAN, INC (2)
- BRAINSTORM CELL THERAPEUTICS INC. (1)
- CALADRIUS BIOSCIENCES, INC. (1)
- CANCER GENETICS, INC (3)
- CAPRICOR THERAPEUTICS, INC. (1)
- CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (3)
- CareDx, Inc. (1)
- Caribou Biosciences, Inc. (1)
- CASI Pharmaceuticals, Inc. (1)
- Celldex Therapeutics, Inc. (1)
- Cellectar Biosciences, Inc. (1)
- Chanticleer Holdings, Inc. (2)
- Chelsea Worldwide Inc. (1)
- Cibus Global, Ltd. (2)
- Clovis Oncology, Inc. (2)
- CTD HOLDINGS INC (2)
- CTI BIOPHARMA CORP (3)
- Curative Biotechnology Inc (6)
- CURIS INC (4)
- Cyclacel Pharmaceuticals, Inc. (3)
- CytoDyn Inc. (6)
- CYTORI THERAPEUTICS, INC. (1)
- Diffusion Pharmaceuticals Inc. (2)
- Digital Development Partners, Inc. (1)
- Emerald Bioscience, Inc. (1)
- ENDONOVO THERAPEUTICS, INC. (3)
- Enochian Biosciences Inc (1)
- Flexion Therapeutics Inc (1)
- FLUOROPHARMA MEDICAL, INC. (1)
- Fortress Biotech, Inc. (2)
- GALECTIN THERAPEUTICS INC (1)
- Gene Biotherapeutics, Inc. (2)
- GENEREX BIOTECHNOLOGY CORP (3)
- Genprex, Inc. (1)
- GeoVax Labs, Inc. (2)
- GT Biopharma, Inc. (2)
- HALOZYME THERAPEUTICS INC (1)
- HedgePath Pharmaceuticals, Inc. (1)
- HEMISPHERX BIOPHARMA INC (5)
- HERON THERAPEUTICS, INC. (2)
- HUMANIGEN, INC (2)
- iBio, Inc. (2)
- IDERA PHARMACEUTICALS, INC. (2)
- IMMUNE PHARMACEUTICALS INC (1)
- INFINITY PHARMACEUTICALS, INC. (3)
- Innovation Pharmaceuticals Inc. (1)
- INTERCEPT PHARMACEUTICALS, INC. (1)
- International Stem Cell CORP (2)
- INTREXON CORP (3)
- Intrinsic Medicine, Inc. (1)
- IRONWOOD PHARMACEUTICALS INC (1)
- Isoray, Inc. (1)
- Leisure Acquisition Corp. (7)
- Locust Walk Acquisition Corp. (2)
- MARIZYME INC (4)
- Marker Therapeutics, Inc. (3)
- Medovex Corp. (5)
- MiMedx Group, Inc. (4)
- NAVIDEA BIOPHARMACEUTICALS, INC. (4)
- NEUROBIOLOGICAL TECHNOLOGIES INC (2)
- NORTHWEST BIOTHERAPEUTICS INC (1)
- NOVAVAX INC (2)
- Novus Therapeutics, Inc. (1)
- NTN BUZZTIME INC (2)
- Nuo Therapeutics, Inc. (3)
- OncBioMune Pharmaceuticals, Inc (7)
- OPGEN INC (1)
- ORAGENICS INC (2)
- Organicell Regenerative Medicine, Inc. (2)
- Outlook Therapeutics, Inc. (1)
- Pfenex Inc. (1)
- PhaseBio Pharmaceuticals Inc (1)
- Propanc Biopharma, Inc. (1)
- Protagenic Therapeutics, Inc. (2)
- Protalix BioTherapeutics, Inc. (1)
- PTC THERAPEUTICS, INC. (2)
- Q BioMed Inc. (1)
- Retrophin, Inc. (1)
- Rich Pharmaceuticals, Inc. (1)
- SELLAS Life Sciences Group, Inc. (1)
- Shuttle Pharmaceuticals Holdings, Inc. (2)
- SOPHIRIS BIO INC. (2)
- Spero Therapeutics, Inc. (1)
- SPHERIX INC (1)
- SUNESIS PHARMACEUTICALS INC (1)
- Synthetic Biologics, Inc. (1)
- T2 Biosystems, Inc. (1)
- TG THERAPEUTICS, INC. (1)
- Tonix Pharmaceuticals Holding Corp. (1)
- United Therapeutics Corp (2)
- VACCINEX, INC. (2)
- VBI Vaccines Inc (1)
- Vertex Pharmaceuticals Inc (1)
- VICAL INC (2)
- VistaGen Therapeutics, Inc. (2)
- WINDTREE THERAPEUTICS INC (4)
- Xenetic Biosciences, Inc. (3)
- Amended and Restated Security Agreement (OncBioMune Pharmaceuticals, Inc, Filed With SEC on August 21, 2023)
- Security Agreement, dated August 7, 2023, by and between Ayala Pharmaceuticals, Inc. and Israel Biotech Fund I, L.P (Advaxis, Inc., Filed With SEC on August 10, 2023)
- SECURITY AGREEMENT (SECURITIES ACCOUNT) (Arcturus Therapeutics Holdings Inc., Filed With SEC on August 7, 2023)
- Form of Security Agreement (ADiTx Therapeutics, Inc., Filed With SEC on July 28, 2023)
- Security Agreement, dated as of July 11, 2023, by and between Aceragen, Inc. and NovaQuest Co-Investment Fund XV, L.P (IDERA PHARMACEUTICALS, INC., Filed With SEC on July 11, 2023)
- Form of Security Agreement (ADiTx Therapeutics, Inc., Filed With SEC on July 7, 2023)
- Security Agreement (Allarity Therapeutics, Inc., Filed With SEC on June 30, 2023)
- Form of Security Agreement (Adhera Therapeutics, Inc., Filed With SEC on June 29, 2023)
- Form of Security Agreement (Adhera Therapeutics, Inc., Filed With SEC on May 5, 2023)
- Form of Security Agreement (Adhera Therapeutics, Inc., Filed With SEC on May 4, 2023)
- Security Agreement dated as of April 26, 2023 (Aridis Pharmaceuticals, Inc., Filed With SEC on May 1, 2023)
- First Amendment to Security Agreement dated as of April 25, 2023 between Navidea Biopharmaceuticals, Inc. and John Kim Scott, Jr (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
- First Amendment to Security Agreement (Allarity Therapeutics, Inc., Filed With SEC on April 12, 2023)
- Amended and Restated Security Agreement, dated March 13, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited (AgeX Therapeutics, Inc., Filed With SEC on March 15, 2023)
- Form of Security Agreement (Adhera Therapeutics, Inc., Filed With SEC on March 8, 2023)
- Trademark Security Agreement, dated February 21, 2023, by and among Gelesis Holdings, Inc., Gelesis, Inc., Gelesis 2012, Inc., Gelesis LLC and PureTech Health LLC (CAPSTAR SPECIAL PURPOSE ACQUISITION CORP., Filed With SEC on February 23, 2023)
- Patent Security Agreement, dated February 21, 2023, by and among Gelesis Holdings, Inc., Gelesis, Inc., Gelesis 2012, Inc., Gelesis LLC and PureTech Health LLC (CAPSTAR SPECIAL PURPOSE ACQUISITION CORP., Filed With SEC on February 23, 2023)
- Security and Pledge Agreement, dated February 21, 2023, by and among Gelesis Holdings, Inc., Gelesis, Inc., Gelesis 2012, Inc., Gelesis LLC and PureTech Health LLC (CAPSTAR SPECIAL PURPOSE ACQUISITION CORP., Filed With SEC on February 23, 2023)
- Form of Security Agreement (Adhera Therapeutics, Inc., Filed With SEC on February 23, 2023)
- Security Agreement (Enochian Biosciences Inc, Filed With SEC on February 23, 2023)
- Form of Contingent Subsidiary Security (Fortress Biotech, Inc., Filed With SEC on February 9, 2023)
- Form of Security Agreement (Adhera Therapeutics, Inc., Filed With SEC on January 26, 2023)
- Pledge and Security Agreement, dated as of January 6, 2023, by and among the Company certain subsidiaries of the Company, as grantors, and the Administrative Agent (Clovis Oncology, Inc., Filed With SEC on January 12, 2023)
- Form of Security Agreement (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on January 12, 2023)
- Form of Intellectual Property Security Agreement (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on January 12, 2023)
- Form of Security Agreement (OncBioMune Pharmaceuticals, Inc, Filed With SEC on December 1, 2022)
- Security Agreement between Registrant and Mast Hill Fund, L.P (Digital Development Partners, Inc., Filed With SEC on November 14, 2022)
- Intellectual Property Security Agreement for March 2022 Offering (Curative Biotechnology Inc, Filed With SEC on November 7, 2022)
- Security Agreement for March 2022 Offering (Curative Biotechnology Inc, Filed With SEC on November 7, 2022)
- Intellectual Property Security Agreement for March 2022 Offering (Curative Biotechnology Inc, Filed With SEC on September 9, 2022)
- Security Agreement for March 2022 Offering (Curative Biotechnology Inc, Filed With SEC on September 9, 2022)
- Commercial Security Agreement between the Registrant and East West Bank, dated May 23, 2022 (CASI Pharmaceuticals, Inc., Filed With SEC on August 12, 2022)
- Form of Security Agreement (ADiTx Therapeutics, Inc., Filed With SEC on August 10, 2022)
- Security Agreement, dated June 30, 2022, by and among the Company, EBI OpCo, Inc., Covistat, Inc. and the other parties signatory thereto (Leisure Acquisition Corp., Filed With SEC on July 6, 2022)
- Security Agreement, dated as of May 24, 2022, by and among Halozyme Therapeutics, Inc., the Guarantors and Bank of America N.A (HALOZYME THERAPEUTICS INC, Filed With SEC on May 24, 2022)
- Security Agreement, dated May 17, 2022, by Clene Nanomedicine, Inc. in favor of the Department of Housing of Community Development, a principal department of the State of Maryland (Chelsea Worldwide Inc., Filed With SEC on May 19, 2022)
- Security Agreement between Cellvera Global Holdings LLC and Aditxt, Inc. dated as of March 31, 2022 (ADiTx Therapeutics, Inc., Filed With SEC on May 16, 2022)
- Security Agreement between Cellvera Holdings and Aditxt, Inc. dated as of March 31, 2022 (ADiTx Therapeutics, Inc., Filed With SEC on May 16, 2022)
- Form of Security Agreement dated May 11, 2022 (Adhera Therapeutics, Inc., Filed With SEC on May 16, 2022)
- Security Agreement between Cellvera Development LLC and Aditxt, Inc. dated as of March 31, 2022 (ADiTx Therapeutics, Inc., Filed With SEC on May 16, 2022)
